Synergistic and Antagonistic Drug Combinations against SARS-CoV-2

DOI record: { "DOI": "10.1016/j.ymthe.2020.12.016", "ISSN": [ "1525-0016" ], "URL": "http://dx.doi.org/10.1016/j.ymthe.2020.12.016", "alternative-id": [ "S1525001620306730" ], "assertion": [ { "label": "This article is maintained by", "name": "publisher", "value": "Elsevier" }, { "label": "Article Title", "name": "articletitle", "value": "Synergistic and Antagonistic Drug Combinations against SARS-CoV-2" }, { "label": "Journal Title", "name": "journaltitle", "value": "Molecular Therapy" }, { "label": "CrossRef DOI link to publisher maintained version", "name": "articlelink", "value": "https://doi.org/10.1016/j.ymthe.2020.12.016" }, { "label": "Content Type", "name": "content_type", "value": "article" }, { "label": "Copyright", "name": "copyright", "value": "© 2020 The American Society of Gene and Cell Therapy." } ], "author": [ { "affiliation": [], "family": "Bobrowski", "given": "Tesia", "sequence": "first" }, { "affiliation": [], "family": "Chen", "given": "Lu", "sequence": "additional" }, { "affiliation": [], "family": "Eastman", "given": "Richard T.", "sequence": "additional" }, { "affiliation": [], "family": "Itkin", "given": "Zina", "sequence": "additional" }, { "affiliation": [], "family": "Shinn", "given": "Paul", "sequence": "additional" }, { "affiliation": [], "family": "Chen", "given": "Catherine Z.", "sequence": "additional" }, { "affiliation": [], "family": "Guo", "given": "Hui", "sequence": "additional" }, { "affiliation": [], "family": "Zheng", "given": "Wei", "sequence": "additional" }, { "affiliation": [], "family": "Michael", "given": "Sam", "sequence": "additional" }, { "affiliation": [], "family": "Simeonov", "given": "Anton", "sequence": "additional" }, { "affiliation": [], "family": "Hall", "given": "Matthew D.", "sequence": "additional" }, { "affiliation": [], "family": "Zakharov", "given": "Alexey V.", "sequence": "additional" }, { "ORCID": "https://orcid.org/0000-0003-4616-7036", "affiliation": [], "authenticated-orcid": false, "family": "Muratov", "given": "Eugene N.", "sequence": "additional" } ], "container-title": "Molecular Therapy", "container-title-short": "Molecular Therapy", "content-domain": { "crossmark-restriction": true, "domain": [ "cell.com", "elsevier.com", "sciencedirect.com" ] }, "created": { "date-parts": [ [ 2020, 12, 16 ] ], "date-time": "2020-12-16T11:00:26Z", "timestamp": 1608116426000 }, "deposited": { "date-parts": [ [ 2022, 2, 3 ] ], "date-time": "2022-02-03T20:47:56Z", "timestamp": 1643921276000 }, "funder": [ { "DOI": "10.13039/100000002", "award": [ "1U01CA207160", "OT2R002514", "OT3TR002020" ], "doi-asserted-by": "publisher", "id": [ { "asserted-by": "publisher", "id": "10.13039/100000002", "id-type": "DOI" } ], "name": "National Institutes of Health" }, { "DOI": "10.13039/100006108", "doi-asserted-by": "publisher", "id": [ { "asserted-by": "publisher", "id": "10.13039/100006108", "id-type": "DOI" } ], "name": "National Center for Advancing Translational Sciences" } ], "indexed": { "date-parts": [ [ 2025, 2, 21 ] ], "date-time": "2025-02-21T02:46:08Z", "timestamp": 1740105968407, "version": "3.37.3" }, "is-referenced-by-count": 85, "issue": "2", "issued": { "date-parts": [ [ 2021, 2 ] ] }, "journal-issue": { "issue": "2", "published-print": { "date-parts": [ [ 2021, 2 ] ] } }, "language": "en", "license": [ { "URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "content-version": "tdm", "delay-in-days": 0, "start": { "date-parts": [ [ 2021, 2, 1 ] ], "date-time": "2021-02-01T00:00:00Z", "timestamp": 1612137600000 } }, { "URL": "http://creativecommons.org/licenses/by-nc-nd/4.0/", "content-version": "vor", "delay-in-days": 367, "start": { "date-parts": [ [ 2022, 2, 3 ] ], "date-time": "2022-02-03T00:00:00Z", "timestamp": 1643846400000 } } ], "link": [ { "URL": "https://api.elsevier.com/content/article/PII:S1525001620306730?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining" }, { "URL": "https://api.elsevier.com/content/article/PII:S1525001620306730?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining" } ], "member": "78", "original-title": [], "page": "873-885", "prefix": "10.1016", "published": { "date-parts": [ [ 2021, 2 ] ] }, "published-print": { "date-parts": [ [ 2021, 2 ] ] }, "publisher": "Elsevier BV", "reference": [ { "DOI": "10.1086/653080", "article-title": "The hepatitis C virus (HCV) NS4B RNA binding inhibitor clemizole is highly synergistic with HCV protease inhibitors", "author": "Einav", "doi-asserted-by": "crossref", "first-page": "65", "journal-title": "J. Infect. Dis.", "key": "10.1016/j.ymthe.2020.12.016_bib1", "volume": "202", "year": "2010" }, { "DOI": "10.1016/j.antiviral.2016.11.017", "article-title": "Synergistic drug combination effectively blocks Ebola virus infection", "author": "Sun", "doi-asserted-by": "crossref", "first-page": "165", "journal-title": "Antiviral Res.", "key": "10.1016/j.ymthe.2020.12.016_bib2", "volume": "137", "year": "2017" }, { "DOI": "10.1124/pr.58.3.10", "article-title": "Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies", "author": "Chou", "doi-asserted-by": "crossref", "first-page": "621", "journal-title": "Pharmacol. Rev.", "key": "10.1016/j.ymthe.2020.12.016_bib3", "volume": "58", "year": "2006" }, { "DOI": "10.1126/scitranslmed.3006667", "article-title": "High-Throughput Methods for Combinatorial Drug Discovery", "author": "Sun", "doi-asserted-by": "crossref", "first-page": "205rv1", "journal-title": "Sci. Transl. Med", "key": "10.1016/j.ymthe.2020.12.016_bib4", "volume": "5", "year": "2013" }, { "DOI": "10.1016/j.virusres.2020.198146", "article-title": "Scaffold morphing of arbidol (umifenovir) in search of multi-targeting therapy halting the interaction of SARS-CoV-2 with ACE2 and other proteases involved in COVID-19", "author": "Choudhary", "doi-asserted-by": "crossref", "first-page": "198146", "journal-title": "Virus Res.", "key": "10.1016/j.ymthe.2020.12.016_bib5", "volume": "289", "year": "2020" }, { "DOI": "10.1016/j.ijantimicag.2020.105998", "article-title": "Arbidol: A potential antiviral drug for the treatment of SARS-CoV-2 by blocking trimerization of the spike glycoprotein", "author": "Vankadari", "doi-asserted-by": "crossref", "first-page": "105998", "journal-title": "Int. J. Antimicrob. Agents", "key": "10.1016/j.ymthe.2020.12.016_bib6", "volume": "56", "year": "2020" }, { "DOI": "10.1038/s41586-020-2286-9", "article-title": "A SARS-CoV-2 protein interaction map reveals targets for drug repurposing", "author": "Gordon", "doi-asserted-by": "crossref", "first-page": "459", "journal-title": "Nature", "key": "10.1016/j.ymthe.2020.12.016_bib7", "volume": "583", "year": "2020" }, { "DOI": "10.1038/s41467-019-09799-2", "article-title": "Community assessment to advance computational prediction of cancer drug combinations in a pharmacogenomic screen", "author": "Menden", "doi-asserted-by": "crossref", "first-page": "2674", "journal-title": "Nat. Commun.", "key": "10.1016/j.ymthe.2020.12.016_bib8", "volume": "10", "year": "2019" }, { "DOI": "10.1016/S0140-6736(20)31042-4", "article-title": "Triple combination of interferon beta-1b, lopinavir-ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial", "author": "Hung", "doi-asserted-by": "crossref", "first-page": "1695", "journal-title": "Lancet", "key": "10.1016/j.ymthe.2020.12.016_bib9", "volume": "395", "year": "2020" }, { "DOI": "10.1056/NEJMoa2001282", "article-title": "A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19", "author": "Cao", "doi-asserted-by": "crossref", "first-page": "1787", "journal-title": "N. Engl. J. Med.", "key": "10.1016/j.ymthe.2020.12.016_bib10", "volume": "382", "year": "2020" }, { "DOI": "10.1056/NEJMoa2007764", "article-title": "Remdesivir for the Treatment of Covid-19—Preliminary Report", "author": "Beigel", "doi-asserted-by": "crossref", "first-page": "1813", "journal-title": "N. Engl. J. Med", "key": "10.1016/j.ymthe.2020.12.016_bib11", "volume": "383", "year": "2020" }, { "article-title": "Viribus Unitis: Drug Combinations as a Treatment Against COVID-19", "author": "Muratov", "journal-title": "chemRxiv", "key": "10.1016/j.ymthe.2020.12.016_bib12", "year": "2020" }, { "DOI": "10.1038/s41589-020-0510-4", "article-title": "Drug antagonism and single-agent dominance result from differences in death kinetics", "author": "Richards", "doi-asserted-by": "crossref", "first-page": "791", "journal-title": "Nat. Chem. Biol.", "key": "10.1016/j.ymthe.2020.12.016_bib13", "volume": "16", "year": "2020" }, { "DOI": "10.1111/j.1600-0676.1992.tb01045.x", "article-title": "Intracellular distribution and effect of the antimalarial drug mefloquine on lysosomes of rat liver", "author": "Glaumann", "doi-asserted-by": "crossref", "first-page": "183", "journal-title": "Liver", "key": "10.1016/j.ymthe.2020.12.016_bib14", "volume": "12", "year": "1992" }, { "DOI": "10.1021/acscentsci.0c00489", "article-title": "Remdesivir: A Review of Its Discovery and Development Leading to Emergency Use Authorization for Treatment of COVID-19", "author": "Eastman", "doi-asserted-by": "crossref", "first-page": "672", "journal-title": "ACS Cent. Sci.", "key": "10.1016/j.ymthe.2020.12.016_bib15", "volume": "6", "year": "2020" }, { "DOI": "10.1128/AAC.02350-13", "article-title": "Metabolism and pharmacokinetics of the anti-hepatitis C virus nucleotide prodrug GS-6620", "author": "Murakami", "doi-asserted-by": "crossref", "first-page": "1943", "journal-title": "Antimicrob. Agents Chemother.", "key": "10.1016/j.ymthe.2020.12.016_bib16", "volume": "58", "year": "2014" }, { "DOI": "10.1136/bmj.m1432", "article-title": "Chloroquine and hydroxychloroquine in covid-19", "author": "Ferner", "doi-asserted-by": "crossref", "first-page": "m1432", "journal-title": "BMJ", "key": "10.1016/j.ymthe.2020.12.016_bib17", "volume": "369", "year": "2020" }, { "DOI": "10.1016/j.jiph.2016.04.001", "article-title": "Nitazoxanide, a new drug candidate for the treatment of Middle East respiratory syndrome coronavirus", "author": "Rossignol", "doi-asserted-by": "crossref", "first-page": "227", "journal-title": "J. Infect. Public Health", "key": "10.1016/j.ymthe.2020.12.016_bib18", "volume": "9", "year": "2016" }, { "DOI": "10.1038/s41422-020-0282-0", "article-title": "Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro", "author": "Wang", "doi-asserted-by": "crossref", "first-page": "269", "journal-title": "Cell Res.", "key": "10.1016/j.ymthe.2020.12.016_bib19", "volume": "30", "year": "2020" }, { "DOI": "10.1016/j.isci.2019.07.003", "article-title": "The FDA-Approved Oral Drug Nitazoxanide Amplifies Host Antiviral Responses and Inhibits Ebola Virus", "author": "Jasenosky", "doi-asserted-by": "crossref", "first-page": "1279", "journal-title": "iScience", "key": "10.1016/j.ymthe.2020.12.016_bib20", "volume": "19", "year": "2019" }, { "DOI": "10.1371/journal.ppat.1002976", "article-title": "Niclosamide Is a Proton Carrier and Targets Acidic Endosomes with Broad Antiviral Effects", "author": "Jurgeit", "doi-asserted-by": "crossref", "first-page": "e1002976", "journal-title": "PLoS Pathog", "key": "10.1016/j.ymthe.2020.12.016_bib21", "volume": "8", "year": "2012" }, { "article-title": "Dose prediction for repurposing nitazoxanide in SARS-CoV-2 treatment or chemoprophylaxis", "author": "Rajoli", "journal-title": "medRxiv", "key": "10.1016/j.ymthe.2020.12.016_bib22", "year": "2020" }, { "DOI": "10.5414/CPP40213", "article-title": "Nitazoxanide pharmacokinetics and tolerability in man using single ascending oral doses", "author": "Stockis", "doi-asserted-by": "crossref", "first-page": "213", "journal-title": "Int. J. Clin. Pharmacol. Ther.", "key": "10.1016/j.ymthe.2020.12.016_bib23", "volume": "40", "year": "2002" }, { "article-title": "Early use of nitazoxanide in mild Covid-19 disease: randomized, placebo-controlled trial", "author": "Rocco", "journal-title": "medRxiv", "key": "10.1016/j.ymthe.2020.12.016_bib24", "year": "2020" }, { "article-title": "Comparative analysis of antiviral efficacy of FDA-approved drugs against SARS-CoV-2 in human lung cells: Nafamostat is the most potent antiviral drug candidate", "author": "Ko", "journal-title": "bioRxiv", "key": "10.1016/j.ymthe.2020.12.016_bib25", "year": "2020" }, { "DOI": "10.1038/s41586-020-2577-1", "article-title": "Discovery of SARS-CoV-2 antiviral drugs through large-scale compound repurposing", "author": "Riva", "doi-asserted-by": "crossref", "first-page": "113", "journal-title": "Nature", "key": "10.1016/j.ymthe.2020.12.016_bib26", "volume": "586", "year": "2020" }, { "DOI": "10.1186/s13073-020-00763-0", "article-title": "Characterisation of the transcriptome and proteome of SARS-CoV-2 reveals a cell passage induced in-frame deletion of the furin-like cleavage site from the spike glycoprotein", "author": "Davidson", "doi-asserted-by": "crossref", "first-page": "68", "journal-title": "Genome Med.", "key": "10.1016/j.ymthe.2020.12.016_bib27", "volume": "12", "year": "2020" }, { "DOI": "10.1099/jgv.0.001481", "article-title": "SARS-CoV-2 growth, furin-cleavage-site adaptation and neutralization using serum from acutely infected hospitalized COVID-19 patients", "author": "Klimstra", "doi-asserted-by": "crossref", "first-page": "1156", "journal-title": "J. Gen. Virol.", "key": "10.1016/j.ymthe.2020.12.016_bib28", "volume": "101", "year": "2020" }, { "article-title": "Furin Cleavage Site Is Key to SARS-CoV-2 Pathogenesis", "author": "Johnson", "journal-title": "bioRxiv", "key": "10.1016/j.ymthe.2020.12.016_bib29", "year": "2020" }, { "DOI": "10.1128/AAC.02282-12", "article-title": "Pharmacokinetics, metabolism, and excretion of the antiviral drug arbidol in humans", "author": "Deng", "doi-asserted-by": "crossref", "first-page": "1743", "journal-title": "Antimicrob. Agents Chemother.", "key": "10.1016/j.ymthe.2020.12.016_bib30", "volume": "57", "year": "2013" }, { "DOI": "10.1021/acs.jcim.7b00589", "article-title": "Chemotext: A Publicly Available Web Server for Mining Drug-Target-Disease Relationships in PubMed", "author": "Capuzzi", "doi-asserted-by": "crossref", "first-page": "212", "journal-title": "J. Chem. Inf. Model.", "key": "10.1016/j.ymthe.2020.12.016_bib31", "volume": "58", "year": "2018" }, { "DOI": "10.1021/acs.jcim.9b00683", "article-title": "ROBOKOP KG and KGB: Integrated Knowledge Graphs from Federated Sources", "author": "Bizon", "doi-asserted-by": "crossref", "first-page": "4968", "journal-title": "J. Chem. Inf. Model.", "key": "10.1016/j.ymthe.2020.12.016_bib32", "volume": "59", "year": "2019" }, { "article-title": "COVID-KOP: Integrating Emerging COVID-19 Data with the ROBOKOP Database", "author": "Korn", "journal-title": "chemRxiv", "key": "10.1016/j.ymthe.2020.12.016_bib33", "year": "2020" }, { "DOI": "10.1002/minf.201000061", "article-title": "Best Practices for QSAR Model Development, Validation, and Exploitation", "author": "Tropsha", "doi-asserted-by": "crossref", "first-page": "476", "journal-title": "Mol. Inform.", "key": "10.1016/j.ymthe.2020.12.016_bib34", "volume": "29", "year": "2010" }, { "DOI": "10.1016/j.drudis.2015.09.003", "article-title": "Modelling of compound combination effects and applications to efficacy and toxicity: state-of-the-art, challenges and perspectives", "author": "Bulusu", "doi-asserted-by": "crossref", "first-page": "225", "journal-title": "Drug Discov. Today", "key": "10.1016/j.ymthe.2020.12.016_bib35", "volume": "21", "year": "2016" }, { "DOI": "10.1021/acs.molpharmaceut.5b00762", "article-title": "QSAR Modeling and Prediction of Drug-Drug Interactions", "author": "Zakharov", "doi-asserted-by": "crossref", "first-page": "545", "journal-title": "Mol. Pharm.", "key": "10.1016/j.ymthe.2020.12.016_bib36", "volume": "13", "year": "2016" }, { "DOI": "10.1093/bioinformatics/btz604", "article-title": "ROBOKOP: an abstraction layer and user interface for knowledge graphs to support question answering", "author": "Morton", "doi-asserted-by": "crossref", "first-page": "5382", "journal-title": "Bioinformatics", "key": "10.1016/j.ymthe.2020.12.016_bib37", "volume": "35", "year": "2019" }, { "DOI": "10.1111/cts.12592", "article-title": "The Biomedical Data Translator Program: Conception, Culture, and Community", "doi-asserted-by": "crossref", "first-page": "91", "journal-title": "Clin. Transl. Sci.", "key": "10.1016/j.ymthe.2020.12.016_bib38", "volume": "12", "year": "2019" }, { "key": "10.1016/j.ymthe.2020.12.016_bib39", "series-title": "An AI challenge with AI2, CZI, MSR, Georgetown, NIH, and the White House. Kaggle", "year": "2020" }, { "DOI": "10.1021/acs.jcim.9b00526", "article-title": "Novel Consensus Architecture To Improve Performance of Large-Scale Multitask Deep Learning QSAR Models", "author": "Zakharov", "doi-asserted-by": "crossref", "first-page": "4613", "journal-title": "J. Chem. Inf. Model.", "key": "10.1016/j.ymthe.2020.12.016_bib40", "volume": "59", "year": "2019" }, { "article-title": "QSAR modeling of SARS-CoV Mpro inhibitors identifies Sufugolix, Cenicriviroc, Proglumetacin and other drugs as candidates for repurposing against SARS-CoV-2", "author": "Alves", "journal-title": "Mol. Inform", "key": "10.1016/j.ymthe.2020.12.016_bib41", "year": "2020" }, { "DOI": "10.1039/D0CS00098A", "article-title": "QSAR without borders", "author": "Muratov", "doi-asserted-by": "crossref", "first-page": "3525", "journal-title": "Chem. Soc. Rev.", "key": "10.1016/j.ymthe.2020.12.016_bib42", "volume": "49", "year": "2020" }, { "DOI": "10.1021/jm4004285", "article-title": "QSAR modeling: where have you been? Where are you going to?", "author": "Cherkasov", "doi-asserted-by": "crossref", "first-page": "4977", "journal-title": "J. Med. Chem.", "key": "10.1016/j.ymthe.2020.12.016_bib43", "volume": "57", "year": "2014" }, { "DOI": "10.1021/ci100176x", "article-title": "Trust, but verify: on the importance of chemical structure curation in cheminformatics and QSAR modeling research", "author": "Fourches", "doi-asserted-by": "crossref", "first-page": "1189", "journal-title": "J. Chem. Inf. Model.", "key": "10.1016/j.ymthe.2020.12.016_bib44", "volume": "50", "year": "2010" }, { "DOI": "10.1021/acs.jcim.6b00129", "article-title": "Trust, but Verify II: A Practical Guide to Chemogenomics Data Curation", "author": "Fourches", "doi-asserted-by": "crossref", "first-page": "1243", "journal-title": "J. Chem. Inf. Model.", "key": "10.1016/j.ymthe.2020.12.016_bib45", "volume": "56", "year": "2016" }, { "DOI": "10.1038/nchembio.1881", "article-title": "Curation of chemogenomics data", "author": "Fourches", "doi-asserted-by": "crossref", "first-page": "535", "journal-title": "Nat. Chem. Biol.", "key": "10.1016/j.ymthe.2020.12.016_bib46", "volume": "11", "year": "2015" }, { "DOI": "10.1016/S1093-3263(01)00123-1", "article-title": "Beware of q2!", "author": "Golbraikh", "doi-asserted-by": "crossref", "first-page": "269", "journal-title": "J. Mol. Graph. Model.", "key": "10.1016/j.ymthe.2020.12.016_bib47", "volume": "20", "year": "2002" }, { "DOI": "10.1002/minf.201100129", "article-title": "Existing and Developing Approaches for QSAR Analysis of Mixtures", "author": "Muratov", "doi-asserted-by": "crossref", "first-page": "202", "journal-title": "Mol. Inform.", "key": "10.1016/j.ymthe.2020.12.016_bib48", "volume": "31", "year": "2012" }, { "article-title": "An OpenData portal to share COVID-19 drug repurposing data in real time", "author": "Brimacombe", "journal-title": "bioRxiv", "key": "10.1016/j.ymthe.2020.12.016_bib49", "year": "2020" }, { "DOI": "10.1002/prp2.149", "article-title": "Analysis of drug combinations: current methodological landscape", "author": "Foucquier", "doi-asserted-by": "crossref", "first-page": "e00149", "journal-title": "Pharmacol. Res. Perspect.", "key": "10.1016/j.ymthe.2020.12.016_bib50", "volume": "3", "year": "2015" } ], "reference-count": 50, "references-count": 50, "relation": { "has-preprint": [ { "asserted-by": "object", "id": "10.1101/2020.06.29.178889", "id-type": "doi" } ] }, "resource": { "primary": { "URL": "https://linkinghub.elsevier.com/retrieve/pii/S1525001620306730" } }, "score": 1, "short-title": [], "source": "Crossref", "subject": [], "subtitle": [], "title": "Synergistic and Antagonistic Drug Combinations against SARS-CoV-2", "type": "journal-article", "update-policy": "https://doi.org/10.1016/elsevier_cm_policy", "volume": "29" }